• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

The 14th US-Japan Cellular and Gene Therapy Conference Agenda

on
Induced Pluripotent Stem Cells (iPS): Derivation and Characterization

Natcher Conference Center
Building 45, Balcony A and B, National Institutes of Health
Bethesda, Maryland 20892

Thursday, February 24, 2011


The conference is jointly supported by the Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration (FDA) and the Ministry of Education, Culture, Sports, Science and Technology, Japan under the US-Japan Cooperative Research Program. The goal of this conference is to exchange ideas on cutting edge areas of biomedical research and to enhance opportunities for collaborations among scientists from the US and Japan. The scientific theme of our joint annual meetings has been diverse. We have invited speakers from Japan and the US to discuss advances in this emerging field of research and highlight FDA's regulations in this cutting-edge field of biomedical research.

Seating is limited to 200 attendees and is on a first-come-first-served basis. No prior registration is required. For more information, please contact Dr. Syed R Husain by e-mailing syed.husain@fda.hhs.gov or phone at (301) 827-0475.


Program


8:00 a.m. – 8:30 a.m.Registration
Coffee and Breakfast
ModeratorSyed Husain, Senior Staff Scientist, Division of Cellular and Gene Therapies, CBER, US Food and Drug Administration, Bethesda, Maryland
8:30 a.m. – 8:35 a.m.Opening Remarks
Carolyn Wilson
, Associate Director of Research, CBER, US Food and Drug Administration, Bethesda, Maryland
8:35 a.m. – 8:40 a.m.Yoshikazu Ohya, Professor, Department of Integrated Biosciences Graduate School of Frontier Sciences, University of Tokyo, Japan

AM Session


ModeratorsYoshikazu Ohya, Professor, Department of Integrated Biosciences Graduate School of Frontier Sciences, University of Tokyo, Japan
Steven Bauer, Chief, Cellular and Tissue Therapy Branch, Division of Cellular and Gene Therapies, CBER, FDA, Bethesda, Maryland
8:40 a.m. – 9:10 a.m.Generation of Platelets from Pluripotent Stem Cells
Hiromitsu Nakauchi, Professor and Director, Division of Stem Cell Therapy, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo
9:10 a.m. – 9:40 a.m.A Comprehensive Comparison of Induced Pluripotent Stem Cells to Human Embryonic Stem Cells
Barbara Mallon, NIH Stem Cell Unit, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland
9:40 a.m. – 10:10 a.m.Lessons from Developmental Biology to Generate Functional Liver Cells from iPS Cells
Atsushi Miyajima, Professor and Director, Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo

10:10 a.m. – 10:40 a.m.Coffee Break

10:40 a.m. – 11:10 a.m.Human iPS Cells Derived from Blood Cells by a Non-integrating Plasmid
Linzhao Cheng, Co-Director, Institute for Cell Engineering Stem Cell Program; Department of Medicine Division of Hematology,
Johns Hopkins University School of Medicine, Baltimore, Maryland
11:10 a.m. – 11:40 a.m.Perspectives on Pluripotent Stem Cell-based Therapies: Regulatory and Scientific Issues
Steven Bauer, Chief, Cellular and Tissue Therapy Branch, Division of Cellular and Gene Therapies, CBER, FDA, Bethesda, Maryland

11:40 p.m. – 1:00 p.m.Lunch

PM Session


ModeratorsRicardo Feldman, Associate Professor, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland
Hiromitsu Nakauchi, Professor and Director, Division of Stem Cell Therapy, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo
1:00 p.m. – 1:30 p.m.Design of Cell-recognizable Nanobiomaterials for ES/iPS Cells Proliferation and Hepatocyte Differentiation: Concept of Cell Cooking Plate for Regenerative medicine
Toshihiro Akaike, Professor, Graduate School of Bioscience and Biotechnology, Department of Biomolecular Engineering, Tokyo Institute of Technology, Tokyo
1:30 p.m. – 2:00 p.m.Generation of Patient-specific Induced Pluripotent Stem Cells for Modeling and Treating Gaucher Disease
Ricardo Feldman, Associate Professor, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland
2:00 p.m. – 2:30 p.m.Application of iPS Cell Technology for NKT Cell-targeted Adjuvant Therapy for Tumors in Mice
Haruhiko Koseki, Group Director, RIKEN Research Center for Allergy and Immunology, Yokohama

2:30 p.m. – 3:00 p.m.Coffee Break

3:00 p.m. – 3:30 p.m.iPS Cell Research for Cardiovascular Regeneration
Jun Yamashita, Associate Professor, Laboratory of Stem Cell Differentiation, Institute for Frontier Medical Sciences, Kyoto University
3:30 p.m. – 4:00 p.m.New Insights on Genomic Stability and Immortality of Pluripotent Stem Cells
Michal Zalzman, Visiting Fellow, Developmental Genomics and Aging Section, Laboratory of Genetics, National Institute on Aging, Baltimore, Maryland
4:00 p.m. – 4:30 p.m.Generation of Induced Pluripotent Stem Cells from Human Peripheral Blood: Less Invasive and Clinically Applicable Technique
Shinsuke Yuasa, Professor, Department of Regenerative Medicine and Advanced Cardiac Therapeutics, Keio University School of Medicine, Tokyo

Thank you for your participation!


Organizers: Syed R Husain, Ph.D.
Raj K Puri, M.D., Ph.D.

Tumor Vaccines and Biotechnology Branch
Division of Cellular and Gene Therapies
NIH Bldg. 29B, Room 2G07, HFM-735
Bethesda, Maryland, 20892
Ph. 301-827-0475; Fax 301-827-0449
syed.husain@fda.hhs.gov
raj.puri@fda.hhs.gov
 
Yoshikazu Ohya, Ph.D.
Professor, Division of Biosciences
Department of Integrated Biosciences
Graduate School of Frontier Sciences
University of Tokyo
Bldg. FSB-101, 5-1-5 Kashiwanoha
Kashiwa, Chiba Prefecture 277-8562
Japan
ohya@k.u-tokyo.ac.jp